Italia markets closed

BMY Aug 2025 65.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,5800-0,1200 (-17,14%)
Alla chiusura: 02:14PM EDT
Schermo intero
Chiusura precedente0,7000
Aperto0,5800
Denaro0,5100
Lettera0,9300
Prezzo d'esercizio65,00
Scadenza2025-08-15
Min-Max giorno0,5800 - 0,5800
Contratto - Min-MaxN/D
Volume2
Open Interest539
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri